Serum spexin in first-degree relatives of patients with type 2 diabetes

被引:0
作者
Salam, M. S. Abdel [1 ]
Mahmoud, E. [1 ]
Abdel-Kareem, S. M. [1 ]
Khidr, E. G. [2 ]
机构
[1] Al Azhar Univ, Fac Med Girls, Dept Endocrinol & Metab, Cairo, Egypt
[2] Al Azhar Univ, Fac Pharm Boys, Dept Biochem & Mol Biol, Nasr City, Cairo, Egypt
来源
MEDICINA DE FAMILIA-SEMERGEN | 2025年 / 51卷 / 06期
关键词
First-degree relatives; Insulin resistance; Spexin; Type; 2; diabetes; INSULIN-RESISTANCE; FAMILY-HISTORY; RISK-FACTORS; ADULTS;
D O I
10.1016/j.semerg.2025.102510
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and aims: Genetic defects significantly contribute to diabetes development, especially in genetically predisposed individuals. First-degree relatives (FDRs) of type 2 diabetes (T2D) patients face an increased risk of developing diabetes. Spexin, a novel neuropeptide, is emerging as a key player in metabolic diseases due to its role in energy homeostasis. This study aims to evaluate, for the first time, serum spexin levels in normoglycemic FDRs of T2D patients, compared to T2D and healthy controls. It also investigates the relationship between spexin levels, insulin resistance, and metabolic parameters. Methods: Ninety participants were included: 30 with T2D, 35 normoglycemic FDRs of T2D patients, and 25 healthy controls. Serum spexin levels were measured using ELISA, along with and glycemic parameters, lipid profiles, and insulin resistance markers. Results: Spexin levels were significantly lower in FDRs compared to controls and even lower in T2D patients, indicating a progressive decline from healthy individuals to those with T2D. Spexin levels negatively correlated with BMI, triglycerides, total cholesterol, LDL-C, fasting blood glucose, insulin, HbA1c, and HOMA-IR, but positively correlated with HDL-C. Conclusion: Lower spexin levels in FDRs of T2D patients may be associated with a higher risk of developing T2D. Spexin levels showed statistically significant negative correlations with key metabolic and cardiovascular risk factors, including BMI (r=-0.302), triglycerides (r=-0.464), total cholesterol (r=-0.524), fasting insulin (r=-0.703), and HOMA-IR (r=-0.565), suggesting that reduced spexin may reflect or contribute to worsening metabolic health and insulin resistance. Monitoring spexin could be useful for identifying individuals at higher risk for T2D and related metabolic disorders. (c) 2025 Sociedad Espanola de Me<acute accent>dicos de Atencio<acute accent>n Primaria (SEMERGEN). Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:8
相关论文
共 36 条
[1]   Inactive matrix Gla protein in relation to diabetic retinopathy in type 2 diabetes [J].
Adel, Hend ;
Fawzy, Olfat ;
Mahmoud, Eman ;
Mohammed, Nesma Sayed ;
Khidr, Emad Gamil .
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) :603-610
[2]   Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes [J].
Ahmed, Fahd ;
AL-Habori, Molham ;
Al-Zabedi, Ebtesam ;
Saif-Ali, Riyadh .
BMC ENDOCRINE DISORDERS, 2021, 21 (01)
[3]   Circulating spexin levels are influenced by the presence or absence of gestational diabetes [J].
Al-Daghri, Nasser M. ;
Sabico, Shaun ;
Al-Hazmi, Hazim ;
Alenad, Amal M. ;
Al-Amro, Abeer ;
Al-Ghamdi, Amani ;
Hussain, Syed Danish ;
Chrousos, George ;
Alokail, Majed S. .
CYTOKINE, 2019, 113 :291-295
[4]  
Bitarafan Vida, 2019, Med J Islam Repub Iran, V33, P93, DOI [10.47176/mjiri.33.93, 10.34171/mjiri.33.93]
[5]   GAL3 receptor KO mice exhibit an anxiety-like phenotype [J].
Brunner, Susanne M. ;
Farzi, Aitak ;
Locker, Felix ;
Holub, Barbara S. ;
Drexel, Meinrad ;
Reichmann, Florian ;
Lang, Andreas A. ;
Mayr, Johannes A. ;
Vilches, Jorge J. ;
Navarro, Xavier ;
Lang, Roland ;
Sperk, Guenther ;
Holzer, Peter ;
Kofler, Barbara .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (19) :7138-7143
[6]   Circulating spexin levels are influenced by the glycemic status and correlated with pancreatic β-cell function in Chinese subjects [J].
Dai, Jiarong ;
Ni, Yunzhi ;
Wu, Di ;
Jiang, Yaojing ;
Jin, Shuoshuo ;
Zhang, Shan ;
Yu, Xuemei ;
Liu, Rui .
ACTA DIABETOLOGICA, 2022, 60 (2) :305-313
[7]   Serum neuregulin 1 in relation to ventricular function and subclinical atherosclerosis in type 2 diabetes patients [J].
Eldin, Aya Saad ;
Fawzy, Olfat ;
Mahmoud, Eman ;
Elaziz, Ola H. Abd ;
Enayet, Alshimaa Ezzat A. ;
Khidr, Emad Gamil .
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (10) :619-627
[8]   Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023 [J].
ElSayed, Nuha A. ;
Aleppo, Grazia ;
Aroda, Vanita R. ;
Bannuru, Raveendhara R. ;
Brown, Florence M. ;
Bruemmer, Dennis ;
Collins, Billy S. ;
Hilliard, Marisa E. ;
Isaacs, Diana ;
Johnson, Eric L. ;
Kahan, Scott ;
Khunti, Kamlesh ;
Leon, Jose ;
Lyons, Sarah K. ;
Perry, Mary Lou ;
Prahalad, Priya ;
Pratley, Richard E. ;
Seley, Jane Jeffrie ;
Stanton, Robert C. ;
Gabbay, Robert A. .
DIABETES CARE, 2023, 46 :S19-S40
[9]   Trends in Diabetes Treatment and Control in US Adults, 1999-2018 [J].
Fang, Michael ;
Wang, Dan ;
Coresh, Josef ;
Selvin, Elizabeth .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23) :2219-2228
[10]   Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside [J].
Grieco, Giuseppina Emanuela ;
Besharat, Zein Mersini ;
Licata, Giada ;
Fignani, Daniela ;
Brusco, Noemi ;
Nigi, Laura ;
Formichi, Caterina ;
Po, Agnese ;
Sabato, Claudia ;
Dardano, Angela ;
Natali, Andrea ;
Dotta, Francesco ;
Sebastiani, Guido ;
Ferretti, Elisabetta .
TRANSLATIONAL RESEARCH, 2022, 247 :137-157